A new trading day began on Friday, with Cogent Biosciences Inc (NASDAQ: COGT) stock price down -7.77% from the previous day of trading, before settling in for the closing price of $9.65. COGT’s price has ranged from $3.67 to $12.61 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -6.78% over the last five years. Meanwhile, its annual earnings per share averaged 1.24%. With a float of $88.93 million, this company’s outstanding shares have now reached $110.46 million.
The firm has a total of 164 workers. Let’s measure their productivity. In terms of profitability, gross margin is 47.39%, operating margin of -4660.58%, and the pretax margin is -4336.02%.
Cogent Biosciences Inc (COGT) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Cogent Biosciences Inc is 21.37%, while institutional ownership is 91.31%.
Cogent Biosciences Inc (COGT) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.63 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1.24% per share during the next fiscal year.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
Here are Cogent Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.48, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -2.29 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Analysing the last 5-days average volume posted by the [Cogent Biosciences Inc, COGT], we can find that recorded value of 1.47 million was better than the volume posted last year of 1.43 million. As of the previous 9 days, the stock’s Stochastic %D was 16.17%. Additionally, its Average True Range was 0.73.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 22.22%, which indicates a significant increase from 2.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 87.13% in the past 14 days, which was higher than the 57.53% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.99, while its 200-day Moving Average is $8.73. Now, the first resistance to watch is $9.44. This is followed by the second major resistance level at $9.97. The third major resistance level sits at $10.28. If the price goes on to break the first support level at $8.60, it is likely to go to the next support level at $8.29. Now, if the price goes above the second support level, the third support stands at $7.76.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
With a market capitalization of 906.70 million, the company has a total of 110,462K Shares Outstanding. Currently, annual sales are 0 K while annual income is -192,410 K. The company’s previous quarter sales were 0 K while its latest quarter income was -58,950 K.
